Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-09-220134
Filing Date
2009-11-02
Accepted
2009-11-02 13:27:46
Documents
10
Period of Report
2009-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 13941
2 EXHIBIT 99.1 dex991.htm EX-99.1 9460
3 EXHIBIT 99.2 dex992.htm EX-99.2 9398
4 EXHIBIT 99.3 dex993.htm EX-99.3 895916
5 GRAPHIC g18998g50w02.jpg GRAPHIC 32732
6 GRAPHIC g18998g72y84.jpg GRAPHIC 8383
7 GRAPHIC g18998g82f19.jpg GRAPHIC 9116
8 GRAPHIC g18998g87e24.jpg GRAPHIC 11685
9 GRAPHIC g18998g97x19.jpg GRAPHIC 35310
10 GRAPHIC g18998g99s40.jpg GRAPHIC 54602
  Complete submission text file 0001193125-09-220134.txt   1140253
Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 091150502
SIC: 2834 Pharmaceutical Preparations